Page History

...

The document is primarily a specification; ongoing development will be through the documentation and actual implementation of the machine readable concept model for the medicinal product hierarchy and population of this model will be directed by the detailed Editorial and Terming Guidance for the hierarchy (see: SNOMED CT Editorial Guide - Medicinal Product).

This document also provides a description of how aspects of the SNOMED medicinal product hierarchy correspond with the suite of standards in ISO, collectively known as the "Identification of Medicinal Products standards" (IDMP).

...

The scope of specification for the concept model for representation of medicinal products in the international edition of SNOMED CT is limited to pharmaceutical and biological products only; products that represent blood products, foods/nutritional supplements, additives, and complementary medicines (including homoeopathic products) are currently out of scope.  The representation of autologous medicinal products (those created from tissue from and administered back to an individual) is also out of scope.  Concepts for vaccines also follow the pattern this model, although only to two of the three "levels" (MP and MPF).  Further detail on scope can be found in the SNOMED CT Editorial GuidanceGuide.

The international medicinal product model and concepts in the international edition will be described in their more abstract form; real or actual products (including branded products and those marketed without a brand name) as authorised by medicines regulatory agencies within jurisdictions are not within scope.  Describing the packages in which medicinal products are placed into the supply chain are also not within scope;  both of these areas are covered in the national model specification.

...